*Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, U.S.A.;
†Mission Neurosciences Program, Epilepsy Department, Mission Health, Asheville, North Carolina, U.S.A.;
‡Department of Neurology and Yale Comprehensive Epilepsy Center, Yale University, New Haven, Connecticut, U.S.A.;
§Neurology Division, Laureate Medical Group, Atlanta, Georgia, U.S.A.;
‖MGH Epilepsy Service and Division of Clinical Neurophysiology, Massachusetts General Hospital, Boston, Massachusetts, U.S.A.
Address correspondence and reprint requests to Anna-Marieta Moise, MD, 890 Hendersonville Rd Suite 200, Asheville, NC 28803, U.S.A.; e-mail: [email protected]
The authors have no conflicts of interest to disclose.
Supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR000454. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Presented at the American Epilepsy Society Meeting, Washington, DC, December, 2017.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.clinicalneurophys.com).